Novel Baroreceptor Activation Therapy
Fig. 8.1 Schematic representation of how baroreceptor activation therapy works. (Courtesy of CVRx Inc.) The Principle of Baroreceptor Activation Therapy Baroreceptors are located in the aortic arch and at the…
Resistant Hypertension in Patients with Chronic Kidney Disease
Fig. 3.1 True resistant hypertension (blue bar) and pseudoresistant hypertension (green bar) in CKD. (Adapted from Nicola et al. [31]. With permission from Elsevier) Observational studies have documented a high…
White-Coat Hypertension: Do We Really Understand It Now?
(n) %WCH Treated hypertensives [5] 12,897 21.4 Male [6] 15,212 24.2 Female [6] 13,936 32.5* Untreated hypertensives [7] 6176 29.2 a *p < 0.001 vs. males aWCH defined as ABP > 135 and/or…
Masked Hypertension: Does It Lead to CVD or CKD?
LVH LVMI LV wall cIMT CV events CVA ESRD Sega et al. [3] Liu et al. [2] Sega et al. [3] Kotsis et al. [5] Bobrie et al. [10] Hara…
Central BP Monitoring, Home BP Monitoring, Ambulatory BP Monitoring in CKD
Central BP assessment obtained by aortic or carotid measurements Provides more accurate assessment of true BP burden of vital organs Better assessment of BP-related cardiovascular risk Arterial compliance by aortic…
Neurogenic Factors in Hypertension Associated With Chronic Kidney Disease
Fig. 4.1 Office BP values at follow-up. Changes in average office BP (a) and mean decrease in office BP (b) at follow-up. Error bars represent SDs. *P < 0.001 versus baseline (before…
Dual Inhibitors: RAAS Blockers/Combination Therapies: What Do All These Trials Mean?
© Springer Science+Business Media New York 2015Matthew R. Weir and Edgar V. Lerma (eds.)Chronic Kidney Disease and HypertensionClinical Hypertension and Vascular Diseases10.1007/978-1-4939-1982-6_6 6. Dual Inhibitors: RAAS Blockers/Combination Therapies: What Do All These Trials Mean? Domenic…
Novel Molecules
Blood pressure mechanism Antihypertensive agent Sympathetic system Human recombinant renalase Renin–angiotensin–aldosterone system Renin inhibitors Anti-angiotensin vaccine Angiotensin II type 2 receptor agonist Aldosterone synthase inhibitor Natriuretic peptide system Vasopeptidase inhibitors…
